Γ-υδροξυβουτυρικό οξύ (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Γ-υδροξυβουτυρικό οξύ" in Greek language version.

refsWebsite

Global rank Greek rank

75nih.gov

4^th place

55doi.org

2^nd place

3^rd place

12archive.org

6^th place

5^th place

11web.archive.org

1^st place

3fda.gov

447^th place

368^th place

2gov.uk

432^nd place

530^th place

2usdoj.gov

2,755^th place

6,623^rd place

1emedicine.com

3,595^th place

2,635^th place

1erowid.org

3,887^th place

4,036^th place

1espacenet.com

800^th place

4,641^st place

1who.int

195^th place

72^nd place

1nytimes.com

7^th place

29^th place

1worldcat.org

5^th place

8^th place

124dash.com

low place

1bbc.co.uk

8^th place

20^th place

1independent.co.uk

36^th place

113^th place

1thenewsherald.com

low place

1forensicmag.com

low place

1gtfch.org

low place

1harvard.edu

18^th place

57^th place

1addictionresource.com

low place

1time.com

61^st place

112^th place

1ualberta.ca

3,600^th place

low place

1rarediseases.org

5,181^st place

2,675^th place

1if-pan.krakow.pl

low place

1zenodo.org

621^st place

1,469^th place

1agenziafarmaco.gov.it

low place

1cdc.gov

218^th place

156^th place

1samhsa.gov

low place

1reuters.com

49^th place

98^th place

1ucsb.edu

1,115^th place

2,626^th place

1whitehousedrugpolicy.gov

low place

1legislation.gov.uk

809^th place

2,944^th place

24dash.com

«No evidence to suggest widespread date rape drug use'». 16 Νοεμβρίου 2006. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Ιανουαρίου 2009. Ανακτήθηκε στις 8 Απριλίου 2014.

addictionresource.com

«GHB Rehab and Treatment Options». AddictionResource.

agenziafarmaco.gov.it

farmaci.agenziafarmaco.gov.it

«Alcover: Riassunto delle Caratteristiche del Prodotto». Agenzia Italiana del Farmaco. 31 Μαρτίου 2017. Index page

archive.org

Weil, Andrew· Rosen, Winifred (1993). «Depressants». From Chocolate to Morphine (2nd έκδοση). Boston/New York: Houghton Mifflin Company. σελ. 77. ISBN 978-0-395-66079-9.
«Abuse and therapeutic potential of gamma-hydroxybutyric acid». Alcohol 20 (3): 263–69. April 2000. doi:10.1016/S0741-8329(99)00090-7. PMID 10869868. https://archive.org/details/sim_alcohol_2000-04_20_3/page/263.
«Gamma-hydroxybutyric acid: an emerging recreational drug». Anaesthesia 53 (12): 1195–98. December 1998. doi:10.1046/j.1365-2044.1998.00603.x. PMID 10193223. https://archive.org/details/sim_anaesthesia_1998-12_53_12/page/1195. «In the UK, GHB has been available in the night clubs around London since 1994...».
«Rave drugs: pharmacological considerations». AANA Journal 72 (1): 61–67. February 2004. PMID 15098519. https://archive.org/details/sim_aana-journal_2004-02_72_1/page/61.
«Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma». The American Journal of Emergency Medicine 29 (3): 319–32. March 2011. doi:10.1016/j.ajem.2009.11.008. PMID 20825811. https://archive.org/details/sim_american-journal-of-emergency-medicine_2011-03_29_3/page/319.
«Adolescent gamma-hydroxybutyric acid exposure decreases cortical N-methyl-D-aspartate receptor and impairs spatial learning». Pharmacology, Biochemistry, and Behavior 79 (4): 701–08. December 2004. doi:10.1016/j.pbb.2004.09.022. PMID 15582677. https://archive.org/details/sim_pharmacology-biochemistry-and-behavior_2004-12_79_4/page/701.
«Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence». Addiction 92 (1): 89–96. January 1997. doi:10.1111/j.1360-0443.1997.tb03640.x. PMID 9060200. https://archive.org/details/sim_british-journal-of-addiction_1997-01_92_1/page/89.
«Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB)». FASEB Journal 17 (12): 1691–93. September 2003. doi:10.1096/fj.02-0846fje. PMID 12958178. https://archive.org/details/sim_faseb-journal_2003-09_17_12/page/1691.
«Gammahydroxybutyrate: an endogenous regulator of energy metabolism». Neuroscience and Biobehavioral Reviews 13 (4): 187–98. 1989. doi:10.1016/S0149-7634(89)80053-3. PMID 2691926. https://archive.org/details/sim_neuroscience-and-biobehavioral-reviews_winter-1989_13_4/page/187.
«Identification of substances formed by decomposition of peak E substance in tryptophan». Food and Chemical Toxicology 30 (1): 71–81. January 1992. doi:10.1016/0278-6915(92)90139-C. PMID 1544609. https://archive.org/details/sim_food-and-chemical-toxicology_1992-01_30_1/page/71.
«A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation». Inflammation Research 54 (11): 435–50. November 2005. doi:10.1007/s00011-005-1380-7. PMID 16307217. https://archive.org/details/sim_inflammation-research_2005-11_54_11/page/435.
«gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity». The American Journal of Emergency Medicine 9 (4): 321–24. July 1991. doi:10.1016/0735-6757(91)90050-t. PMID 2054002. https://archive.org/details/sim_american-journal-of-emergency-medicine_1991-07_9_4/page/321.

bbc.co.uk

news.bbc.co.uk

«Date-rape drugs 'not widespread'». BBC News. 2006-11-16. http://news.bbc.co.uk/1/hi/uk/6152646.stm. Ανακτήθηκε στις 2014-04-08.

cdc.gov

Centers for Disease Control (CDC) (November 1990). «Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate». MMWR. Morbidity and Mortality Weekly Report 39 (47): 861–63. PMID 2122223. https://www.cdc.gov/mmwr/preview/mmwrhtml/00001847.htm.

doi.org

dx.doi.org

«The use of sodium oxybate to treat narcolepsy». Expert Review of Neurotherapeutics 12 (5): 519–29. May 2012. doi:10.1586/ern.12.42. PMID 22550980.
«Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence». Clinical Drug Investigation 34 (1): 63–80. January 2014. doi:10.1007/s40261-013-0158-x. PMID 24307430.
Cochrane Drugs and Alcohol Group, επιμ. (February 2010). «Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses». The Cochrane Database of Systematic Reviews (2): CD006266. doi:10.1002/14651858.CD006266.pub2. PMID 20166080.
«An update on pharmacotherapy for the treatment of fibromyalgia». Expert Opinion on Pharmacotherapy 16 (9): 1347–68. June 2015. doi:10.1517/14656566.2015.1047343. PMID 26001183.
«Sodium oxybate for the treatment of fibromyalgia». Expert Opinion on Pharmacotherapy 12 (11): 1789–98. August 2011. doi:10.1517/14656566.2011.589836. PMID 21679091.
«The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study». Sleep 13 (6): 479–90. December 1990. doi:10.1093/sleep/13.6.479. PMID 2281247.
«Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men». The Journal of Clinical Investigation 100 (3): 745–53. August 1997. doi:10.1172/JCI119587. PMID 9239423.
«Letter to Editor on article: Re: Narcolepsy Review (Aldrich MS: 8-9-91)». The New England Journal of Medicine 324 (4): 270–72. January 1991. doi:10.1056/nejm199101243240416. PMID 1985252.
«Development of a rational scale to assess the harm of drugs of potential misuse». Lancet 369 (9566): 1047–53. March 2007. doi:10.1016/s0140-6736(07)60464-4. PMID 17382831.
«The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol». Clinical Toxicology 50 (6): 458–70. July 2012. doi:10.3109/15563650.2012.702218. PMID 22746383.
«Abuse and therapeutic potential of gamma-hydroxybutyric acid». Alcohol 20 (3): 263–69. April 2000. doi:10.1016/S0741-8329(99)00090-7. PMID 10869868. https://archive.org/details/sim_alcohol_2000-04_20_3/page/263.
«Gamma-hydroxybutyrate and ethanol effects and interactions in humans». Journal of Clinical Psychopharmacology 26 (5): 524–29. October 2006. doi:10.1097/01.jcp.0000237944.57893.28. PMID 16974199.
«GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome». Current Neuropharmacology 13 (1): 47–70. January 2015. doi:10.2174/1570159X13666141210215423. PMID 26074743.
«Suspicious death related to gamma-hydroxybutyrate (GHB) toxicity». Journal of Clinical Forensic Medicine 8 (2): 74–76. June 2001. doi:10.1054/jcfm.2001.0473. PMID 15274975.
«Gamma-hydroxybutyric acid: an emerging recreational drug». Anaesthesia 53 (12): 1195–98. December 1998. doi:10.1046/j.1365-2044.1998.00603.x. PMID 10193223. https://archive.org/details/sim_anaesthesia_1998-12_53_12/page/1195. «In the UK, GHB has been available in the night clubs around London since 1994...».
«Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse». Drug and Alcohol Dependence 104 (1–2): 1–10. September 2009. doi:10.1016/j.drugalcdep.2009.04.012. PMID 19493637.
Busardò, Francesco P.; Jones, Alan W. (January 2015). «GHB Pharmacology and Toxicology: Acute Intoxication, Concentrations in Blood and Urine in Forensic Cases and Treatment of the Withdrawal Syndrome». Current Neuropharmacology 13 (1): 47–70. doi:10.2174/1570159X13666141210215423. ISSN 1570-159X. PMID 26074743.
«The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review». Journal of Psychopharmacology 24 (9): 1281–87. September 2010. doi:10.1177/0269881110363315. PMID 20488831.
«Prevalence of drugs used in cases of alleged sexual assault». Journal of Analytical Toxicology 23 (3): 141–46. 1999. doi:10.1093/jat/23.3.141. PMID 10369321.
«The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies». Alcohol and Alcoholism 34 (1): 15–24. 1999. doi:10.1093/alcalc/34.1.15. PMID 10075397.
«Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma». The American Journal of Emergency Medicine 29 (3): 319–32. March 2011. doi:10.1016/j.ajem.2009.11.008. PMID 20825811. https://archive.org/details/sim_american-journal-of-emergency-medicine_2011-03_29_3/page/319.
«Three deaths associated with use of Xyrem». Sleep Medicine 10 (4): 490–93. April 2009. doi:10.1016/j.sleep.2009.01.005. PMID 19269893.
«Xyrem safety: the debate continues». Sleep Medicine 10 (4): 405–06. April 2009. doi:10.1016/j.sleep.2009.02.002. PMID 19332385.
«Response to Editorial: "Xyrem safety: The debate continues"». Sleep Medicine 11 (1): 108; author reply 108–09. January 2010. doi:10.1016/j.sleep.2009.08.004. PMID 19959395.
«Adolescent gamma-hydroxybutyric acid exposure decreases cortical N-methyl-D-aspartate receptor and impairs spatial learning». Pharmacology, Biochemistry, and Behavior 79 (4): 701–08. December 2004. doi:10.1016/j.pbb.2004.09.022. PMID 15582677. https://archive.org/details/sim_pharmacology-biochemistry-and-behavior_2004-12_79_4/page/701.
«Gamma-hydroxybutyric acid-induced cognitive deficits in the female adolescent rat». Annals of the New York Academy of Sciences 1139 (1): 386–89. October 2008. doi:10.1196/annals.1432.044. PMID 18991885. Bibcode: 2008NYASA1139..386S.
«Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats». Neurochemistry International 50 (3): 564–70. February 2007. doi:10.1016/j.neuint.2006.11.007. PMID 17197055.
«Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo». Metabolic Brain Disease 24 (2): 271–82. June 2009. doi:10.1007/s11011-009-9136-7. PMID 19296210.
«Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence». Addiction 92 (1): 89–96. January 1997. doi:10.1111/j.1360-0443.1997.tb03640.x. PMID 9060200. https://archive.org/details/sim_british-journal-of-addiction_1997-01_92_1/page/89.
«Oral self-administration of gamma-hydroxybutyric acid in the rat». European Journal of Pharmacology 285 (1): 103–07. October 1995. doi:10.1016/0014-2999(95)00493-5. PMID 8846805.
«Baclofen and gamma-hydroxybutyrate withdrawal». Neurocritical Care 8 (3): 430–33. 2008. doi:10.1007/s12028-008-9062-2. PMID 18266111.
«Behavioral analyses of GHB: receptor mechanisms». Pharmacology & Therapeutics 121 (1): 100–14. January 2009. doi:10.1016/j.pharmthera.2008.10.003. PMID 19010351.
«Best evidence topic report. Gammahydroxybutyrate overdose and physostigmine». Emergency Medicine Journal 23 (4): 300–01. April 2006. doi:10.1136/emj.2006.035139. PMID 16549578.
«Best evidence topic report: endotracheal intubation in gamma-hydroxybutyric acid intoxication and overdose». Emergency Medicine Journal 22 (1): 43. January 2005. doi:10.1136/emj.2004.021154. PMID 15611542.
«Suspected GHB overdoses in the emergency department». Journal of Analytical Toxicology 28 (6): 481–84. September 2004. doi:10.1093/jat/28.6.481. PMID 15516299.
«Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage». Journal of Analytical Toxicology 29 (1): 41–47. 2005. doi:10.1093/jat/29.1.41. PMID 15808012.
«Neurochemical and electrophysiological evidence for the existence of a functional gamma-hydroxybutyrate system in NCB-20 neurons». Neuroscience 86 (3): 989–1000. October 1998. doi:10.1016/S0306-4522(98)00085-2. PMID 9692734.
«Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB)». FASEB Journal 17 (12): 1691–93. September 2003. doi:10.1096/fj.02-0846fje. PMID 12958178. https://archive.org/details/sim_faseb-journal_2003-09_17_12/page/1691.
«Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid». Journal of Neurochemistry 87 (3): 722–32. November 2003. doi:10.1046/j.1471-4159.2003.02037.x. PMID 14535954.
«Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics». European Journal of Pharmacology 256 (2): 211–14. April 1994. doi:10.1016/0014-2999(94)90248-8. PMID 7914168.
«Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage». Brain Research 986 (1–2): 181–90. October 2003. doi:10.1016/S0006-8993(03)03252-9. PMID 12965243.
«The presence of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in alcoholic and non-alcoholic beverages». Forensic Science International 151 (2–3): 289–92. July 2005. doi:10.1016/j.forsciint.2005.02.014. PMID 15939164.
«Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence». Neuropharmacology 47 (8): 1146–56. December 2004. doi:10.1016/j.neuropharm.2004.08.019. PMID 15567424.
«Gamma-hydroxybutyrate receptor function studied by the modulation of nitric oxide synthase activity in rat frontal cortex punches». Biochemical Pharmacology 58 (11): 1815–19. December 1999. doi:10.1016/S0006-2952(99)00265-8. PMID 10571257.
«[A mechanism for gamma-hydroxybutyrate (GHB) as a drug and a substance of abuse]» (στα French). Médecine/Sciences 21 (3): 284–89. March 2005. doi:10.1051/medsci/2005213284. PMID 15745703.
«From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?». British Journal of Pharmacology 154 (2): 358–68. May 2008. doi:10.1038/bjp.2008.132. PMID 18475254.
«Blood-brain barrier to H3-gamma-aminobutyric acid in normal and amino oxyacetic acid-treated animals». Neuropharmacology 10 (1): 103–08. January 1971. doi:10.1016/0028-3908(71)90013-X. PMID 5569303.
«Extracellular events induced by gamma-hydroxybutyrate in striatum: a microdialysis study». Journal of Neurochemistry 56 (3): 938–44. March 1991. doi:10.1111/j.1471-4159.1991.tb02012.x. PMID 1847191.
«Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat». European Journal of Pharmacology 284 (1–2): 83–91. September 1995. doi:10.1016/0014-2999(95)00369-V. PMID 8549640.
«Gammahydroxybutyrate: an endogenous regulator of energy metabolism». Neuroscience and Biobehavioral Reviews 13 (4): 187–98. 1989. doi:10.1016/S0149-7634(89)80053-3. PMID 2691926. https://archive.org/details/sim_neuroscience-and-biobehavioral-reviews_winter-1989_13_4/page/187.
Saytzeff, Alexander (1874). «Über die Reduction des Succinylchlorids» (στα German). Liebigs Annalen der Chemie 171 (2): 258–90. doi:10.1002/jlac.18741710216. https://zenodo.org/record/1427333.
«Identification of substances formed by decomposition of peak E substance in tryptophan». Food and Chemical Toxicology 30 (1): 71–81. January 1992. doi:10.1016/0278-6915(92)90139-C. PMID 1544609. https://archive.org/details/sim_food-and-chemical-toxicology_1992-01_30_1/page/71.
«A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation». Inflammation Research 54 (11): 435–50. November 2005. doi:10.1007/s00011-005-1380-7. PMID 16307217. https://archive.org/details/sim_inflammation-research_2005-11_54_11/page/435.
«gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity». The American Journal of Emergency Medicine 9 (4): 321–24. July 1991. doi:10.1016/0735-6757(91)90050-t. PMID 2054002. https://archive.org/details/sim_american-journal-of-emergency-medicine_1991-07_9_4/page/321.
«Gamma hydroxybutyric acid (GHB) intoxication». Academic Emergency Medicine 9 (7): 730–79. July 2002. doi:10.1197/aemj.9.7.730. PMID 12093716.

emedicine.com

Benzer, Theodore I (8 January 2007). Toxicity, Gamma-Hydroxybutyrate. eMedicine. http://www.emedicine.com/emerg/topic848.htm.

erowid.org

"The Vaults Of Erowid". Erowid.org (18 March 2009). Retrieved on 2012-09-27.

espacenet.com

worldwide.espacenet.com

[1], "Production of nonhygroscopic salts of 4-hydroxybutyric acid"

fda.gov

accessdata.fda.gov

fda.gov

«Transcript: FDA Peripheral and Central Nervous System Drugs Advisory Committee Meeting». FDA. 6 Ιουνίου 2001. Αρχειοθετήθηκε από το πρωτότυπο στις 16 Μαΐου 2017. Ανακτήθηκε στις 9 Δεκεμβρίου 2020.

forensicmag.com

«Drink Speaks the Truth: Forensic Investigation of Drug Facilitated Sexual Assaults». 20 Ιουνίου 2013.

gov.uk

Iversen, Les (3 Οκτωβρίου 2013). «ACMD advice on the scheduling of GHB» (PDF). UK Home Office. Ανακτήθηκε στις 23 Οκτωβρίου 2013.
«Circular 001/2015: A Change to the Misuse of Drugs Act 1971: control of AH-7921, LSD–related compounds, tryptamines, and rescheduling of GHB». UK Home Office. 2015.

gtfch.org

Lott, Susanne; Piper, Thomas; Mehling, Lena-Maria; Spottke, Annika; Maas, Alexandra; Thevis, Mario; Madea, Burkhard; Hess, Cornelius (2015). «Measurement of exogenous gamma-hydroxybutyric acid (GHB) in urine using isotope ratio mass spectrometry (IRMS)». Toxichem Krimtech 82: 264. https://www.gtfch.org/cms/images/stories/media/tb/tb2015/Lott_et_al_2015.pdf.

harvard.edu

adsabs.harvard.edu

«Gamma-hydroxybutyric acid-induced cognitive deficits in the female adolescent rat». Annals of the New York Academy of Sciences 1139 (1): 386–89. October 2008. doi:10.1196/annals.1432.044. PMID 18991885. Bibcode: 2008NYASA1139..386S.

if-pan.krakow.pl

«Gamma-hydrobutyric acid (GHB) and its chemical modifications: a review of the GHBergic system». Polish Journal of Pharmacology 56 (1): 43–49. 2004. PMID 15047976. http://www.if-pan.krakow.pl/pjp/pdf/2004/1_43.pdf.

independent.co.uk

"Labs making date-rape drug raided" Αρχειοθετήθηκε 2015-09-25 στο Wayback Machine., The Independent, 10 July 2008.

legislation.gov.uk

«The Misuse of Drugs (Amendment No. 3) (England, Wales and Scotland) Regulations 2014». UK Home Office. 11 Δεκεμβρίου 2014.

nih.gov

ncbi.nlm.nih.gov

«The use of sodium oxybate to treat narcolepsy». Expert Review of Neurotherapeutics 12 (5): 519–29. May 2012. doi:10.1586/ern.12.42. PMID 22550980.
«Novel strategies to treat alcohol dependence with sodium oxybate according to clinical practice». European Review for Medical and Pharmacological Sciences 19 (7): 1315–20. April 2015. PMID 25912595.
«Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence». Clinical Drug Investigation 34 (1): 63–80. January 2014. doi:10.1007/s40261-013-0158-x. PMID 24307430.
Cochrane Drugs and Alcohol Group, επιμ. (February 2010). «Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses». The Cochrane Database of Systematic Reviews (2): CD006266. doi:10.1002/14651858.CD006266.pub2. PMID 20166080.
«An update on pharmacotherapy for the treatment of fibromyalgia». Expert Opinion on Pharmacotherapy 16 (9): 1347–68. June 2015. doi:10.1517/14656566.2015.1047343. PMID 26001183.
«Sodium oxybate for the treatment of fibromyalgia». Expert Opinion on Pharmacotherapy 12 (11): 1789–98. August 2011. doi:10.1517/14656566.2011.589836. PMID 21679091.
«The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study». Sleep 13 (6): 479–90. December 1990. doi:10.1093/sleep/13.6.479. PMID 2281247.
«Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men». The Journal of Clinical Investigation 100 (3): 745–53. August 1997. doi:10.1172/JCI119587. PMID 9239423.
«Letter to Editor on article: Re: Narcolepsy Review (Aldrich MS: 8-9-91)». The New England Journal of Medicine 324 (4): 270–72. January 1991. doi:10.1056/nejm199101243240416. PMID 1985252.
«Development of a rational scale to assess the harm of drugs of potential misuse». Lancet 369 (9566): 1047–53. March 2007. doi:10.1016/s0140-6736(07)60464-4. PMID 17382831.
«The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol». Clinical Toxicology 50 (6): 458–70. July 2012. doi:10.3109/15563650.2012.702218. PMID 22746383.
«Abuse and therapeutic potential of gamma-hydroxybutyric acid». Alcohol 20 (3): 263–69. April 2000. doi:10.1016/S0741-8329(99)00090-7. PMID 10869868. https://archive.org/details/sim_alcohol_2000-04_20_3/page/263.
«Gamma-hydroxybutyrate and ethanol effects and interactions in humans». Journal of Clinical Psychopharmacology 26 (5): 524–29. October 2006. doi:10.1097/01.jcp.0000237944.57893.28. PMID 16974199.
«GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome». Current Neuropharmacology 13 (1): 47–70. January 2015. doi:10.2174/1570159X13666141210215423. PMID 26074743.
«Suspicious death related to gamma-hydroxybutyrate (GHB) toxicity». Journal of Clinical Forensic Medicine 8 (2): 74–76. June 2001. doi:10.1054/jcfm.2001.0473. PMID 15274975.
«Gamma-hydroxybutyric acid: an emerging recreational drug». Anaesthesia 53 (12): 1195–98. December 1998. doi:10.1046/j.1365-2044.1998.00603.x. PMID 10193223. https://archive.org/details/sim_anaesthesia_1998-12_53_12/page/1195. «In the UK, GHB has been available in the night clubs around London since 1994...».
«Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse». Drug and Alcohol Dependence 104 (1–2): 1–10. September 2009. doi:10.1016/j.drugalcdep.2009.04.012. PMID 19493637.
«Rave drugs: pharmacological considerations». AANA Journal 72 (1): 61–67. February 2004. PMID 15098519. https://archive.org/details/sim_aana-journal_2004-02_72_1/page/61.
Busardò, Francesco P.; Jones, Alan W. (January 2015). «GHB Pharmacology and Toxicology: Acute Intoxication, Concentrations in Blood and Urine in Forensic Cases and Treatment of the Withdrawal Syndrome». Current Neuropharmacology 13 (1): 47–70. doi:10.2174/1570159X13666141210215423. ISSN 1570-159X. PMID 26074743.
«The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review». Journal of Psychopharmacology 24 (9): 1281–87. September 2010. doi:10.1177/0269881110363315. PMID 20488831.
«Prevalence of drugs used in cases of alleged sexual assault». Journal of Analytical Toxicology 23 (3): 141–46. 1999. doi:10.1093/jat/23.3.141. PMID 10369321.
«The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies». Alcohol and Alcoholism 34 (1): 15–24. 1999. doi:10.1093/alcalc/34.1.15. PMID 10075397.
«Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma». The American Journal of Emergency Medicine 29 (3): 319–32. March 2011. doi:10.1016/j.ajem.2009.11.008. PMID 20825811. https://archive.org/details/sim_american-journal-of-emergency-medicine_2011-03_29_3/page/319.
«Three deaths associated with use of Xyrem». Sleep Medicine 10 (4): 490–93. April 2009. doi:10.1016/j.sleep.2009.01.005. PMID 19269893.
«Xyrem safety: the debate continues». Sleep Medicine 10 (4): 405–06. April 2009. doi:10.1016/j.sleep.2009.02.002. PMID 19332385.
«Response to Editorial: "Xyrem safety: The debate continues"». Sleep Medicine 11 (1): 108; author reply 108–09. January 2010. doi:10.1016/j.sleep.2009.08.004. PMID 19959395.
«Adolescent gamma-hydroxybutyric acid exposure decreases cortical N-methyl-D-aspartate receptor and impairs spatial learning». Pharmacology, Biochemistry, and Behavior 79 (4): 701–08. December 2004. doi:10.1016/j.pbb.2004.09.022. PMID 15582677. https://archive.org/details/sim_pharmacology-biochemistry-and-behavior_2004-12_79_4/page/701.
«[Effects of subchronic administration of gammahydroxybutyrate (GHB) on spatial working memory in rats]» (στα Spanish). Psicothema 18 (3): 519–24. August 2006. PMID 17296081.
«Gamma-hydroxybutyric acid-induced cognitive deficits in the female adolescent rat». Annals of the New York Academy of Sciences 1139 (1): 386–89. October 2008. doi:10.1196/annals.1432.044. PMID 18991885. Bibcode: 2008NYASA1139..386S.
«Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats». Neurochemistry International 50 (3): 564–70. February 2007. doi:10.1016/j.neuint.2006.11.007. PMID 17197055.
«Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo». Metabolic Brain Disease 24 (2): 271–82. June 2009. doi:10.1007/s11011-009-9136-7. PMID 19296210.
«Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence». Addiction 92 (1): 89–96. January 1997. doi:10.1111/j.1360-0443.1997.tb03640.x. PMID 9060200. https://archive.org/details/sim_british-journal-of-addiction_1997-01_92_1/page/89.
«Oral self-administration of gamma-hydroxybutyric acid in the rat». European Journal of Pharmacology 285 (1): 103–07. October 1995. doi:10.1016/0014-2999(95)00493-5. PMID 8846805.
«Sedative-Hypnotic Drug Withdrawal Syndrome: Recognition And Treatment». Emergency Medicine Practice 19 (3): 1–20. March 2017. PMID 28186869.
«Baclofen and gamma-hydroxybutyrate withdrawal». Neurocritical Care 8 (3): 430–33. 2008. doi:10.1007/s12028-008-9062-2. PMID 18266111.
«Behavioral analyses of GHB: receptor mechanisms». Pharmacology & Therapeutics 121 (1): 100–14. January 2009. doi:10.1016/j.pharmthera.2008.10.003. PMID 19010351.
«Best evidence topic report. Gammahydroxybutyrate overdose and physostigmine». Emergency Medicine Journal 23 (4): 300–01. April 2006. doi:10.1136/emj.2006.035139. PMID 16549578.
«Best evidence topic report: endotracheal intubation in gamma-hydroxybutyric acid intoxication and overdose». Emergency Medicine Journal 22 (1): 43. January 2005. doi:10.1136/emj.2004.021154. PMID 15611542.
«Suspected GHB overdoses in the emergency department». Journal of Analytical Toxicology 28 (6): 481–84. September 2004. doi:10.1093/jat/28.6.481. PMID 15516299.
«Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage». Journal of Analytical Toxicology 29 (1): 41–47. 2005. doi:10.1093/jat/29.1.41. PMID 15808012.
«Neurochemical and electrophysiological evidence for the existence of a functional gamma-hydroxybutyrate system in NCB-20 neurons». Neuroscience 86 (3): 989–1000. October 1998. doi:10.1016/S0306-4522(98)00085-2. PMID 9692734.
«Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB)». FASEB Journal 17 (12): 1691–93. September 2003. doi:10.1096/fj.02-0846fje. PMID 12958178. https://archive.org/details/sim_faseb-journal_2003-09_17_12/page/1691.
«Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid». Journal of Neurochemistry 87 (3): 722–32. November 2003. doi:10.1046/j.1471-4159.2003.02037.x. PMID 14535954.
«Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics». European Journal of Pharmacology 256 (2): 211–14. April 1994. doi:10.1016/0014-2999(94)90248-8. PMID 7914168.
«gamma-Hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo». The Journal of Pharmacology and Experimental Therapeutics 290 (1): 303–09. July 1999. PMID 10381791.
«Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage». Brain Research 986 (1–2): 181–90. October 2003. doi:10.1016/S0006-8993(03)03252-9. PMID 12965243.
«The presence of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in alcoholic and non-alcoholic beverages». Forensic Science International 151 (2–3): 289–92. July 2005. doi:10.1016/j.forsciint.2005.02.014. PMID 15939164.
«Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence». Neuropharmacology 47 (8): 1146–56. December 2004. doi:10.1016/j.neuropharm.2004.08.019. PMID 15567424.
«Gamma-hydroxybutyrate receptor function studied by the modulation of nitric oxide synthase activity in rat frontal cortex punches». Biochemical Pharmacology 58 (11): 1815–19. December 1999. doi:10.1016/S0006-2952(99)00265-8. PMID 10571257.
«[A mechanism for gamma-hydroxybutyrate (GHB) as a drug and a substance of abuse]» (στα French). Médecine/Sciences 21 (3): 284–89. March 2005. doi:10.1051/medsci/2005213284. PMID 15745703.
«Gamma-hydrobutyric acid (GHB) and its chemical modifications: a review of the GHBergic system». Polish Journal of Pharmacology 56 (1): 43–49. 2004. PMID 15047976. http://www.if-pan.krakow.pl/pjp/pdf/2004/1_43.pdf.
«From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?». British Journal of Pharmacology 154 (2): 358–68. May 2008. doi:10.1038/bjp.2008.132. PMID 18475254.
«Blood-brain barrier to H3-gamma-aminobutyric acid in normal and amino oxyacetic acid-treated animals». Neuropharmacology 10 (1): 103–08. January 1971. doi:10.1016/0028-3908(71)90013-X. PMID 5569303.
«Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB (GABAB) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB». The Journal of Pharmacology and Experimental Therapeutics 273 (3): 1534–43. June 1995. PMID 7791129.
«Extracellular events induced by gamma-hydroxybutyrate in striatum: a microdialysis study». Journal of Neurochemistry 56 (3): 938–44. March 1991. doi:10.1111/j.1471-4159.1991.tb02012.x. PMID 1847191.
«A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties». The Journal of Pharmacology and Experimental Therapeutics 255 (2): 657–63. November 1990. PMID 2173754.
«Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat». European Journal of Pharmacology 284 (1–2): 83–91. September 1995. doi:10.1016/0014-2999(95)00369-V. PMID 8549640.
«Gammahydroxybutyrate: an endogenous regulator of energy metabolism». Neuroscience and Biobehavioral Reviews 13 (4): 187–98. 1989. doi:10.1016/S0149-7634(89)80053-3. PMID 2691926. https://archive.org/details/sim_neuroscience-and-biobehavioral-reviews_winter-1989_13_4/page/187.
«[Generalities concerning the experimental study and clinical use of gamma hydroxybutyrate of Na]» (στα French). Agressologie 1: 397–406. October 1960. PMID 13758011.
«Identification of substances formed by decomposition of peak E substance in tryptophan». Food and Chemical Toxicology 30 (1): 71–81. January 1992. doi:10.1016/0278-6915(92)90139-C. PMID 1544609. https://archive.org/details/sim_food-and-chemical-toxicology_1992-01_30_1/page/71.
«A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation». Inflammation Research 54 (11): 435–50. November 2005. doi:10.1007/s00011-005-1380-7. PMID 16307217. https://archive.org/details/sim_inflammation-research_2005-11_54_11/page/435.
Centers for Disease Control (CDC) (November 1990). «Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate». MMWR. Morbidity and Mortality Weekly Report 39 (47): 861–63. PMID 2122223. https://www.cdc.gov/mmwr/preview/mmwrhtml/00001847.htm.
«gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity». The American Journal of Emergency Medicine 9 (4): 321–24. July 1991. doi:10.1016/0735-6757(91)90050-t. PMID 2054002. https://archive.org/details/sim_american-journal-of-emergency-medicine_1991-07_9_4/page/321.
«Gamma hydroxybutyric acid (GHB) intoxication». Academic Emergency Medicine 9 (7): 730–79. July 2002. doi:10.1197/aemj.9.7.730. PMID 12093716.

pubmedcentral.nih.gov

«Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men». The Journal of Clinical Investigation 100 (3): 745–53. August 1997. doi:10.1172/JCI119587. PMID 9239423.
«Gamma-hydroxybutyrate and ethanol effects and interactions in humans». Journal of Clinical Psychopharmacology 26 (5): 524–29. October 2006. doi:10.1097/01.jcp.0000237944.57893.28. PMID 16974199.
«GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome». Current Neuropharmacology 13 (1): 47–70. January 2015. doi:10.2174/1570159X13666141210215423. PMID 26074743.
«Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse». Drug and Alcohol Dependence 104 (1–2): 1–10. September 2009. doi:10.1016/j.drugalcdep.2009.04.012. PMID 19493637.
Busardò, Francesco P.; Jones, Alan W. (January 2015). «GHB Pharmacology and Toxicology: Acute Intoxication, Concentrations in Blood and Urine in Forensic Cases and Treatment of the Withdrawal Syndrome». Current Neuropharmacology 13 (1): 47–70. doi:10.2174/1570159X13666141210215423. ISSN 1570-159X. PMID 26074743.
«Baclofen and gamma-hydroxybutyrate withdrawal». Neurocritical Care 8 (3): 430–33. 2008. doi:10.1007/s12028-008-9062-2. PMID 18266111.
«Behavioral analyses of GHB: receptor mechanisms». Pharmacology & Therapeutics 121 (1): 100–14. January 2009. doi:10.1016/j.pharmthera.2008.10.003. PMID 19010351.
«Best evidence topic report. Gammahydroxybutyrate overdose and physostigmine». Emergency Medicine Journal 23 (4): 300–01. April 2006. doi:10.1136/emj.2006.035139. PMID 16549578.
«Best evidence topic report: endotracheal intubation in gamma-hydroxybutyric acid intoxication and overdose». Emergency Medicine Journal 22 (1): 43. January 2005. doi:10.1136/emj.2004.021154. PMID 15611542.
«From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?». British Journal of Pharmacology 154 (2): 358–68. May 2008. doi:10.1038/bjp.2008.132. PMID 18475254.

nlm.nih.gov

«Sodium Oxybate: MedlinePlus Drug Information». Nlm.nih.gov. 28 Ιουλίου 2010. Ανακτήθηκε στις 1 Αυγούστου 2010.

nytimes.com

Press, The Associated (12 May 1999). «Warning on Risk of 'Party Drug' Chemicals». The New York Times. https://www.nytimes.com/1999/05/12/us/warning-on-risk-of-party-drug-chemicals.html.

rarediseases.org

National Organization for Rare Disorders. Succinic Semialdehyde Dehydrogenase Deficiency. Retrieved 6 March 2010.

reuters.com

Perry, Michael; Pomfret, James; Crabb, Roger Perry (7 November 2007). «Australia bans China-made toy on toxic drug risk». Reuters. https://www.reuters.com/article/worldNews/idUSSYD2129620071107.

samhsa.gov

store.samhsa.gov

«GHB: A Club Drug To Watch». Substance Abuse Treatment Advisory 2 (1). November 2002. Αρχειοθετήθηκε από το πρωτότυπο στις 1 August 2017. https://web.archive.org/web/20170801221141/https://store.samhsa.gov/shin/content/SMA03-3766/SMA03-3766.pdf. Ανακτήθηκε στις 16 April 2018.

thenewsherald.com

Martin, Jackie Harrison (16 January 2009). "Remembering Samantha Reid: 10th anniversary of teen's GHB death" Αρχειοθετήθηκε 2016-03-04 στο Wayback Machine.. thenewsherald.com. Retrieved on 2012-09-27.

time.com

Addiction and the Brain Αρχειοθετήθηκε 2010-07-24 στο Wayback Machine.. Time

ualberta.ca

«GHB: An Important Pharmacologic and Clinical Update». Ualberta.ca. Ανακτήθηκε στις 1 Αυγούστου 2010.

ucsb.edu

presidency.ucsb.edu

«William J. Clinton: Statement on Signing the Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000». 18 Φεβρουαρίου 2000.

usdoj.gov

US Drug Enforcement Administration. «GHB, GBL and 1,4BD as Date Rape Drugs». Αρχειοθετήθηκε από το πρωτότυπο στις 10 Μαΐου 2012. Ανακτήθηκε στις 10 Μαΐου 2012.

deadiversion.usdoj.gov

«2000 – Addition of Gamma-Hydroxybutyric Acid to Schedule I». US Department of Justice via the Federal Register. 13 Μαρτίου 2000. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Μαΐου 2021. Ανακτήθηκε στις 9 Δεκεμβρίου 2020.

web.archive.org

US Drug Enforcement Administration. «GHB, GBL and 1,4BD as Date Rape Drugs». Αρχειοθετήθηκε από το πρωτότυπο στις 10 Μαΐου 2012. Ανακτήθηκε στις 10 Μαΐου 2012.
«No evidence to suggest widespread date rape drug use'». 16 Νοεμβρίου 2006. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Ιανουαρίου 2009. Ανακτήθηκε στις 8 Απριλίου 2014.
Alcohol and other popular Date Rape Drugs. udel.edu
"Labs making date-rape drug raided" Αρχειοθετήθηκε 2015-09-25 στο Wayback Machine., The Independent, 10 July 2008.
Martin, Jackie Harrison (16 January 2009). "Remembering Samantha Reid: 10th anniversary of teen's GHB death" Αρχειοθετήθηκε 2016-03-04 στο Wayback Machine.. thenewsherald.com. Retrieved on 2012-09-27.
Zvosec et al. Proceedings of the American Academy of Forensic Science in Seattle, 2006. Web.archive.org (3 December 2007). Retrieved on 2011-12-24.
Addiction and the Brain Αρχειοθετήθηκε 2010-07-24 στο Wayback Machine.. Time
«GHB: A Club Drug To Watch». Substance Abuse Treatment Advisory 2 (1). November 2002. Αρχειοθετήθηκε από το πρωτότυπο στις 1 August 2017. https://web.archive.org/web/20170801221141/https://store.samhsa.gov/shin/content/SMA03-3766/SMA03-3766.pdf. Ανακτήθηκε στις 16 April 2018.
«Transcript: FDA Peripheral and Central Nervous System Drugs Advisory Committee Meeting». FDA. 6 Ιουνίου 2001. Αρχειοθετήθηκε από το πρωτότυπο στις 16 Μαΐου 2017. Ανακτήθηκε στις 9 Δεκεμβρίου 2020.
«2000 – Addition of Gamma-Hydroxybutyric Acid to Schedule I». US Department of Justice via the Federal Register. 13 Μαρτίου 2000. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Μαΐου 2021. Ανακτήθηκε στις 9 Δεκεμβρίου 2020.
«Gamma Hydroxybutyrate (GHB)». 2002. Αρχειοθετήθηκε από το πρωτότυπο στις 31 Δεκεμβρίου 2005. Ανακτήθηκε στις 20 Νοεμβρίου 2016.

whitehousedrugpolicy.gov

«Gamma Hydroxybutyrate (GHB)». 2002. Αρχειοθετήθηκε από το πρωτότυπο στις 31 Δεκεμβρίου 2005. Ανακτήθηκε στις 20 Νοεμβρίου 2016.

who.int

«Critical review of gamma-hydroxybutyric acid (GHB)» (PDF). 2012.

worldcat.org

Busardò, Francesco P.; Jones, Alan W. (January 2015). «GHB Pharmacology and Toxicology: Acute Intoxication, Concentrations in Blood and Urine in Forensic Cases and Treatment of the Withdrawal Syndrome». Current Neuropharmacology 13 (1): 47–70. doi:10.2174/1570159X13666141210215423. ISSN 1570-159X. PMID 26074743.

zenodo.org

Saytzeff, Alexander (1874). «Über die Reduction des Succinylchlorids» (στα German). Liebigs Annalen der Chemie 171 (2): 258–90. doi:10.1002/jlac.18741710216. https://zenodo.org/record/1427333.